Understanding and overcoming resistance to PARP inhibitors in cancer therapy

MP Dias, SC Moser, S Ganesan… - Nature reviews Clinical …, 2021 - nature.com
Developing novel targeted anticancer therapies is a major goal of current research. The use
of poly (ADP-ribose) polymerase (PARP) inhibitors in patients with homologous …
被引用次数：259 相关文章

Understanding and overcoming resistance to PARP inhibitors in cancer therapy

MP Dias, SC Moser, S Ganesan… - Nature Reviews …, 2021 - researchwithrutgers.com
Developing novel targeted anticancer therapies is a major goal of current research. The use
of poly (ADP-ribose) polymerase (PARP) inhibitors in patients with homologous …

Understanding and overcoming resistance to PARP inhibitors in cancer therapy.

MP Dias, SC Moser, S Ganesan… - Nature reviews. Clinical …, 2021 - europepmc.org
Developing novel targeted anticancer therapies is a major goal of current research. The use
of poly (ADP-ribose) polymerase (PARP) inhibitors in patients with homologous …

[引用][C] Understanding and overcoming resistance to PARP inhibitors in cancer therapy

MP Dias, SC Moser, S Ganesan, J Jonkers - Nature Reviews Clinical …, 2021 - cir.nii.ac.jp
Understanding and overcoming resistance to PARP inhibitors in cancer therapy | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Understanding and overcoming resistance to PARP inhibitors in cancer therapy

MP Dias, SC Moser, S Ganesan… - Nature reviews …, 2021 - pubmed.ncbi.nlm.nih.gov
Developing novel targeted anticancer therapies is a major goal of current research. The use
of poly (ADP-ribose) polymerase (PARP) inhibitors in patients with homologous …